BioSkryb Genomics is a pioneering company in single-cell analysis, offering patented technologies like Primary Template-directed Amplification (PTA) and the Base Jumper™ bioinformatics platform. Their products, including Resolve OME™ and Resolve DNA®, enable comprehensive genomic and transcriptomic analysis from individual cells, addressing the critical need for precision in understanding cellular heterogeneity and disease mechanisms. With a strong focus on cancer research and a commitment to advancing treatment development, BioSkryb is positioned as a leader in the rapidly evolving field of single-cell genomics, supported by strategic partnerships and a robust intellectual property portfolio.
Something looks off?On-site & Remote